tiprankstipranks
Abbott Laboratories Shs UnSponsored Canadian Depository Receipt Hedged (TSE:ABT)
TSX:ABT
Canadian Market

Abbott Laboratories Shs UnSponsored Canadian Depository Receipt Hedged (ABT) Income Statement

2 Followers

Abbott Laboratories Shs UnSponsored Canadian Depository Receipt Hedged Income Statement

Last quarter (Q3 2020), Abbott Laboratories Shs UnSponsored Canadian Depository Receipt Hedged's total revenue was $28.50M, an increase of 11.08% from the same quarter last year. In Q3, Abbott Laboratories Shs UnSponsored Canadian Depository Receipt Hedged's net income was $2.60M. See Abbott Laboratories Shs UnSponsored Canadian Depository Receipt Hedged’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Jun 20Jun 19Jun 18
Total Revenue
$ 104.67M$ 98.91M$ 93.62M
Gross Profit
$ 92.04M$ 85.93M$ 79.26M
Operating Expenses
$ 76.78M$ 75.03M$ 76.38M
Depreciation and Amortization
$ 5.32M$ 3.42M$ 12.40M
EBITDA
$ 21.18M$ 14.53M$ 15.26M
Operating Income
$ 15.27M$ 10.90M$ 2.88M
Other Income/Expenses
$ -24.50K$ 209.09K$ -18.52K
Pretax Income
$ 15.24M$ 11.11M$ 2.86M
Net Income
$ 10.63M$ 7.58M$ 3.11M
Per Share Metrics
Basic EPS
$ 0.24$ 0.18$ 0.08
Diluted EPS
$ 0.24$ 0.18$ 0.08
Weighted Average Shares Outstanding
44.75M 42.11M 40.03M
Weighted Average Shares Outstanding (Diluted)
44.75M 42.11M 40.03M
Currency in USD

Abbott Laboratories Shs UnSponsored Canadian Depository Receipt Hedged Earnings and Revenue History